2024 annual financial data
Sionna Therapeutics 2024 Operating margin
Sionna Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -70,556,000 USD and net income was -61,688,000 USD.
Operating cash flow was -52,787,000 USD.
Get free Sionna Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -70,556,000 USD
- Net income
- -61,688,000 USD
- Operating cash flow
- -52,787,000 USD